TREACE MEDICAL CONCEPTS, INC. ·
TMCI 8-K 2026-11-06
TREACE MEDICAL CONCEPTS, INC. (TMCI) 8-K dated 2026-11-06 — accession 0001193125-26-450715.
TREACE MEDICAL CONCEPTS, INC. (TMCI) is a medical devices company listed on NASDAQ.
TMCI: Treace Medical Concepts Reports Third Quarter 2026 Financial Results
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported TMCI revenue for 2025-12-31 was $212.7M. Net income was -$59.0M. Revenue was up 1.6% from 2024-12-31 to 2025-12-31. TMCI currently screens at market cap $260.1M.
Not investment advice. The TMCI SEC hub lists recent forms. The stock page is the research view.
- Guidance
- full-year 2026 revenue guidance to be in the range of $206 million to $210 million, from the prior range of $204 million to $212
Why it matters
- full-year 2026 revenue guidance to be in the range of $206 million to $210 million, from the prior range of $204 million to $212